Industry News: Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar - Join them here
Industry News: UNC lands $40M to make personalized cancer vaccines using AI
Industry News: The first-ever personalized cancer vaccine to pass a phase 3 trial just beat Keytruda alone
Industry News: Moderna shares jump 175% on skin cancer trial success
December 1-3, 2026 | Boston, MA
11:29 am - Thursday 3rd December 2026